POP HEALTH FORUM: A HIMSS EVENT
Boston, MA - April 3 - 4, 2017
As director of Payer and Life Sciences for HIMSS, Shelley Price’s responsibilities include guiding the association’s activities around data and analytics – including accountable care organizations, secondary use of data, and clinical & business intelligence (C&BI) – through leading the C&BI Committee, Task Forces and Community of over 8,400 members to turn data in to action. In these roles, she works with HIMSS volunteers, industry leaders, and other subject matter experts to develop content materials whitepapers, educational sessions, thought leadership, and other resources and tools to deliver on the triple-aim of value-based healthcare. She is also a national speaker on data and analytics, and driving to a value-based health system through new care delivery and payment models.
Shelley has worked on healthcare policy in Washington for more than a dozen years. She began her career as associate director of governmental Issues for a prominent Washington, D.C.-based law firm specializing in energy, the environment, natural resources, and health care. While there, she was a part of the team that represented a Fortune 25 company that is one of the world’s largest health care services company and a leader in health information technology and pharmaceutical supply management.
Shelley obtained her bachelors of science degree from the University of Michigan and her masters of science from Johns Hopkins University, Krieger School of Arts and Sciences. She is a HIMSS Fellow and past board member of the Arlington Virginia Chapter of the League of Women Voters.
With newly elected President Donald Trump pushing an agenda to repeal and replace the ACA, healthcare organizations find themselves in a world of uncertainty. What does this uncertainty mean for population health management? How does it affect strategy, purchasing, and implementation? Do you stay the course? Put the brakes on? Or some of both?
Our panel of experts will address this head on. Likewise, in keeping with the panel’s state-of-the-industry format, they’ll also address topics key to pop health success, such as clinical workflow improvement, decreasing utilization, data visualization, choosing vendors, measuring results, and more.
This session will provide attendees with a great overview and set the stage for the sessions to follow.